AAAAAA
Results:
1-11
|
Results: 11
Authors:
Cohen, PA
Peng, LM
Kjaergaard, J
Plautz, GE
Finke, JH
Koski, GK
Czerniecki, BJ
Shu, SY
Citation: Pa. Cohen et al., T-cell adoptive therapy of tumors: Mechanisms of improved therapeutic performance, CR R IMMUN, 21(1-3), 2001, pp. 215-248
Authors:
Seeley, BM
Barthel, SW
To, WC
Kjaergaard, J
Shu, S
Plautz, GE
Citation: Bm. Seeley et al., Potent effector function of tumor-sensitized L-selectin(low) T cells against subcutaneous tumors requires LFA-1 costimulation, OTO H N SUR, 124(4), 2001, pp. 436-441
Authors:
Kjaergaard, J
Peng, LM
Cohen, PA
Drazba, JA
Weinberg, AD
Shu, SY
Citation: J. Kjaergaard et al., Augmentation versus inhibition: Effects of conjunctional OX-40 receptor monoclonal antibody and IL-2 treatment on adoptive immunotherapy of advanced tumor, J IMMUNOL, 167(11), 2001, pp. 6669-6677
Authors:
Kim, JA
Averbook, BJ
Chambers, K
Rothchild, K
Kjaergaard, J
Papay, R
Shu, SY
Citation: Ja. Kim et al., Divergent effects of 4-1BB antibodies on antitumor immunity and on tumor-reactive T-cell generation, CANCER RES, 61(5), 2001, pp. 2031-2037
Authors:
Kjaergaard, J
Andersson, M
Citation: J. Kjaergaard et M. Andersson, Incidence rates of malignant mesothelioma in Denmark and predicted future number of cases among men, SC J WORK E, 26(2), 2000, pp. 112-117
Authors:
Kjaergaard, J
Hokland, ME
Agger, R
Skovbo, A
Nannmark, U
Basse, PH
Citation: J. Kjaergaard et al., Biodistribution and tumor localization of lymphokine-activated killer T cells following different routes of administration into tumor-bearing animals, CANCER IMMU, 48(10), 2000, pp. 550-560
Authors:
Bytzer, P
Aalykke, C
Rune, S
Weywadt, L
Gjorup, T
Eriksen, J
Bonnevie, O
Bekker, C
Kromann-Andersen, H
Kjaergaard, J
Rask-Madsen, J
Vilien, M
Hansen, J
Justesen, T
Vyberg, M
Teglbjaerg, PS
Citation: P. Bytzer et al., Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease - A randomized trial with 2-year follow-up, SC J GASTR, 35(10), 2000, pp. 1023-1032
Authors:
Peng, LM
Kjaergaard, J
Plautz, GE
Weng, DE
Shu, SY
Cohen, PA
Citation: Lm. Peng et al., Helper-independent, L-selectin(low) CD8(+) T cells with broad anti-tumor efficacy are naturally sensitized during tumor progression, J IMMUNOL, 165(10), 2000, pp. 5738-5749
Authors:
Kjaergaard, J
Tanaka, J
Kim, JA
Rothchild, K
Weinberg, A
Shu, SY
Citation: J. Kjaergaard et al., Therapeutic efficacy of OX-40 receptor antibody depends on tumor immunogenicity and anatomic site of tumor growth, CANCER RES, 60(19), 2000, pp. 5514-5521
Authors:
Kjaergaard, J
Shu, SY
Citation: J. Kjaergaard et Sy. Shu, Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression, J IMMUNOL, 163(2), 1999, pp. 751-759
Authors:
Mukai, S
Kjaergaard, J
Shu, SY
Plautz, GE
Citation: S. Mukai et al., Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy, CANCER RES, 59(20), 1999, pp. 5245-5249
Risultati:
1-11
|